released and referenced on Yahoo?
under 20 million as of reported on 12/31/2015 @ 19,876,278
The issue was our Partner, Eisai dropped the ball in a big way. I mean if you remember LC was fired to stating he was expecting 150 million in first year. Jack echoed that 200 million would be on the table if L.C. was correct. Then we hit 30 million for the year.... Big let down.
However, Once the CVOT is completed all doubt about safety will be finally put to rest. 15 years of study proving Belviq is safe and effective. It will open up markets all over the world and doctors will start writing scripts. We will just have to wait for 2 more years.
I don't think so... Mexico is a black hole, Brazil followed Swiss Medic and Canada needed additional information.... EU was supposed to be refiled by end of March 2016 according to Eisai but the last CC from Arena changed that expectation and left when and if wide open. So EU seems to be off the table for a while. I will bet it is off the table until we get some information from the CVOT study.
After the CVOT study is complete I think we will see Belviq become the behemoth we all thought it would become. Doctors once and for all will have 15 years of study proving Belviq is safe and effective. It will be the study that opens the flood gates for Belviq all over the world......
Hopefully Eisai is not at the helm at that point... Someone that is big enough and has enough expertise and captial to make Belviq a world wide brand in 2 short years.
That is their business model. Discover compounds, partner and collaborate, outsource funding expenses and control a profitable drug pipeline with revenue streams for years to come....
2nd collaboration deal in 6 months with a very large world wide Pharma. Farming out the other compounds not the ones in Phase 2 studies..... Just buying time until the game changing news comes in 12 months.
Hedge, why bash this very large company? Seriously? See the forest for the trees. This company is very large and they are now a partner or ours. Building our drug portfolio and potential future cash flows... That is good news but only the 1st quarter.
Or you can read they were not willing to give away something worth so much today. They are waiting to get the Phase 2 results to send shock waves through the buy out community..
I don't really care where the price goes short term and you should not either. Today with all of the games and manipulation it important to buy for the big picture... They do everything they can to create gut wrenching pain for small retail longs and large tute holders.... They need them to sell since they did not do the DD in the first place and now need to manipulate and bully to gain a stock position..
To bad the SEC is so worthless.
down from almost 26 million shares short. That is a very large drop for a 2 week period.
12/15/2015 25,669,891 .
11/30/2015 24,926,257 .
11/13/2015 24,340,204 .
Where are you getting that? Here is what is said about them.
The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 146 affiliates and a total of more than 47,700 employees. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine
That is not what was posted. The post stated no more approvals until 6 mandated tests completed. That is an outright lie. And that p I st has nothing to do with sales chart.
What I posted above would not hurt you in any way. It is clearly bringing attention to the study being completed and getting the opportunity to restate the Phase 2 results of Belviq and getting it in the Press again.
You always want to keep positive news in the press about your company,.. Something current management has not done and has no clue how to create excitement... Other then stating in a flat boring way how excited they are.... with no results.
That is where I run in a differnt league. I would release a PR saying the study has been completed and we are excited to see the results and anticipate this will help many smokers takes the plunge to quit. I would also remind them that Phase 2 reaults showed 3 times the efficacy as Chantix and during that study our participants actually lost weight. Drawing attention to the future release of the data.